Hello,
I am in the process of expanding Medication safety in my system. What type of structure do other systems/hospitals have? Currently, I report up to Quality with no other pharmacists. My thought/research has shown a structure of either a Manager/Director with other medication safety officers reporting up to the manager.
Thank you,
Jen

Hi there,

Has anyone instituted 30 or 60 days expirations on the flavoring oils used in Anesthesia masks? We are worried about contamination if they are kept to the full manufacturer expiration date.

Thanks!
Shannon

Does anyone have a list of non-controlled medications that are susceptible to diversion among healthcare workers? Our compliance officer is interested in using non-controlled meds like triggers to help identify employees that may be diverting or otherwise masking controlled substance issues.

Our system has converted vincristine to IVPB to prevent mishaps with inadvertent intrathecal administration. However, we are now faced with other low volume pediatric IV chemo regimens. Our peds group would like these delivered in IV syringes rather than IVPB to decrease volumes lost in IVPB tubing. These regimens are different than vincristine type regimens (IE no IT meds accompanying), but I don’t want to overlook something. How are others handling low volume chemo agents? Do I need to worry about inadvertent intrathecal administrations with other non-vincristine-based regimens?

We have a shortage of NS vials used by nursing for reconstitution. They want to use flush NS syringes which is concerning if medication were to be drawn back up into the flush syringe. Though, we are also simultaneously experiencing a shortage of 50mL and 100mL NS mini-bags so it is tough to recommend that due to shortage and waste issues.

Good Afternoon,

Has your institution developed a policy on biosimilars? Are you willing to share that policy?

Thank you!

Good Morning,

In our institution we record and report adverse drug reactions that happen in our infusion center dependent on severity. I was wondering if any of you have decided which ADRs to record for checkpoint inhibitors? Do you record it based on the severity of the grading system toxicity? thank you

We are a small critical access hospital that does not have on site pharmacy services 24:7. We follow the TJC standard "to a tee" and do not stock concentrated electrolytes outside of the pharmacy, including potassium phosphate. We are routinely called in from home to mix potassium phosphate (or sodium phosphate) infusions. Something I read recently made me think... can't we safety store this concentrated electrolyte outside of the pharmacy in a secured location in the form of a kit with clear instructions for use? Does anyone else do this?

Hello,
Can you share what your institution is doing in light if the SWFI shortage?
Thank you!